EPIDIOLEX
@epidiolex.com
Discover EPIDIOLEX® (cannabidiol), the only FDA-approved CBD for seizures associated with LGS, Dravet syndrome, or TSC. See important safety information.
EPIDIOLEX's Company Logos
EPIDIOLEX's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#852166
Disco
133, 33, 102
319, 60, 33
0, 75, 23, 48
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#0B1E37
Blue Zodiac
11, 30, 55
214, 67, 13
80, 45, 0, 78
About EPIDIOLEX
EPIDIOLEX is a brand that offers the first and only FDA-approved prescription CBD for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, and tuberous sclerosis complex (TSC) in patients aged 1 year and older. This innovative treatment option provides relief for individuals with hard-to-treat epilepsies. Clinical study results have shown that EPIDIOLEX significantly reduces drop seizures in people living with LGS, with a monthly reduction of up to 42% in the 20 mg/kg/day dose group.
Similarly, for individuals with Dravet syndrome, EPIDIOLEX reduces convulsive seizures, with a monthly reduction of up to 39% in the 20 mg/kg/day dose group. For those with TSC, EPIDIOLEX reduces the frequency of seizures by half. The brand has been extensively tested, with over 500 participants in clinical studies for LGS and Dravet syndrome, and over 200 participants for TSC.
EPIDIOLEX offers hope and improved quality of life for patients living with these conditions
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
